This Record Contains Information About the Mepolizumab Compassionate Use Product Activities: 104317: An Open-Label Compassionate Use and Long-Term Access Study of Mepolizumab in HES. 201956: A Long-term Access Programme for Subjects With Severe Asthma
Expanded access is currently available for this treatment.
Verified September 2017 by GlaxoSmithKline
First Posted: October 27, 2005
Last Update Posted: September 4, 2017
Information provided by (Responsible Party):